Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06887 SUNSHINE PHARMA
RT Nominal up53.600 +1.300 (+2.486%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--000
Property, plant, equip. & others3,853,422-1.107%3,896,5633,732,0003,528,052
Land & other Lease Assets482,789-2.354%494,427447,536474,457
Intangible Assets1,562,691-0.684%1,573,4561,605,0451,914,857
Interests in Asso. & JCEs25,5130.192%25,46412,5710
Other Non-current Assets1,548,71660.848%962,844448,471620,969

7,473,1317.484%6,952,7546,245,6236,538,335
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories759,9122.994%737,821528,980366,473
Trade Receivables1,630,760-5.329%1,722,5561,906,387808,652
Cash & Bank Balances1,036,905-29.977%1,480,8101,920,158971,510
Other Current Assets1,162,74012.063%1,037,5732,056,9512,004,013
Assets Held for Sale0--000

4,590,317-7.802%4,978,7606,412,4764,150,648
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables1,360,9812.264%1,330,856844,366744,776
S-T Debt & Leases2,561,18514.473%2,237,3723,320,9003,947,719
Other Current Liabilities1,027,099-17.570%1,246,0232,013,2254,265,814
Liab asso w/ Assets Held for Sale0--000

4,949,2652.804%4,814,2516,178,4918,958,309
Net Current Assets(358,948)--164,509233,985(4,807,661)
Total Assets Less Current Liabilities7,114,183-0.043%7,117,2636,479,6081,730,674
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases2,251,991-5.648%2,386,8092,029,8912,332,718
Other Non-current Liabilities258,607-1.653%262,954274,398271,891

2,510,598-5.252%2,649,7632,304,2892,604,609
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital463,9430.000%463,943463,943279,627
  Reserves(72,760)-39.262%(119,794)(136,022)(3,968,311)
  Others0--000
Shareholders' Funds391,18313.667%344,149327,921(3,688,684)
Non-controlling Interests4,212,4022.160%4,123,3513,847,3982,814,749
Others0--000

4,603,5853.046%4,467,5004,175,319(873,935)
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments----745,1071,071,441803,881
Contingent Liabilities----000
Remarks:  Real time quote last updated: 12/09/2025 11:14
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -46,370
%Change--
EPS / (LPS)RMB -0.110
NBV Per Share (¥)RMB --
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.